Neurohormonal modulation as therapeutic avenue for right ventricular dysfunction in pulmonary artery hypertension: till the dawn, waiting.
Emanuel R, Chichra A, Patel N, Le Jemtel TH, Jaiswal A. Neurohormonal modulation as therapeutic avenue for right ventricular dysfunction in pulmonary artery hypertension: till the dawn, waiting. Annals Of Translational Medicine 2018, 6: 301. PMID: 30211189, PMCID: PMC6123204, DOI: 10.21037/atm.2018.06.04.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsPulmonary arterial hypertensionRight ventricular dysfunctionRV dysfunctionVentricular dysfunctionManagement of PAHAldosterone system modulationNeuro-hormonal activationPulmonary artery hypertensionBeta-adrenergic blockadeNon-pharmacological modalitiesCurrent clinical experienceArtery hypertensionArterial hypertensionNeurohormonal activationPAH patientsSystemic hypotensionAdrenergic blockadePathophysiological backgroundSignificant morbidityNeurohormonal modulationClinical studiesClinical experienceSystem modulationDysfunctionTherapeutic avenues